Franklin India Prima Plus-G    Plan:
Add to My Watchlist
4 Value Research




 
 Current Stats & Profile
Latest NAV   248.0207 (22/05/13)
52-Week High   259.5659 (15/01/13)
52-Week Low   201.0289 (23/05/12)
Fund Category   Equity: Large & Mid Cap
Type   Open End
Launch Date   September  1994
Risk Grade   Below Average
Return Grade   Above Average
Net Assets (Cr) *   1,952.66 (31/03/13) 
Benchmark   CNX 500
* Quarterly Average
 
 Trailing Returns
As on 22 May 2013 Fund Category
Year to Date -1.71 -0.72
1-Month 3.48 3.42
3-Month 0.64 2.09
1-Year 22.55 21.86
3-Year 9.30 6.29
5-Year 8.06 5.18
Return Since Launch 18.78 --
Returns upto 1 year are absolute and over 1 year are annualised.
 Relative Performance (Fund Vs Category Average)

 Portfolio Summary
 Top Holdings    As on 30 Apr
 Name of Holding   % Net Assets
Bharti Airtel    7.49
ICICI Bank    7.45
Infosys    5.28
HDFC Bank    4.71
Dr. Reddy's Lab    4.20

View additional holdings information
 
Top 5 Sectors % Net Asset
As on 30/04/2013
Financial   24.53
Energy   13.41
Healthcare   11.88
Automobile   7.61
Communication   7.49
   Indicates an increase or decrease or no change in holding since last portfolio
 Indicates a new holding since last portfolio.
 News and Analysis
Headline Date Story Type
Franklin India Prima Plus: Dividend Declaration   11 Feb 2013   Fund News
Value Orientation   27 Nov 2012   Fund Family Update
Franklin India Prima Plus Declares a Dividend of Rs. 2.50 per unit   27 Feb 2012   Fund News
Sector Fund Merger   01 Dec 2011   Fundwire
Merger of Franklin FMCG and Franklin Pharma into Franklin India Prima Plus   05 Aug 2011   Fund News
30% Dividend under Franklin India Prima Plus   14 Feb 2011   Fund News
Change in Fund Management Responsibilities under Franklin Templeton Mutual Fund   03 Feb 2011   Fund News
Transaction Facility under Franklin Templeton Mutual Fund   11 Mar 2010   Fund News
60% Dividend under Franklin India Prima Plus   15 Feb 2010   Fund News
Franklin India Prima Plus Declares Dividends @ 25 per cent   19 Feb 2009   Fund News

View all news/stories related to this fund
Value Research Star Rating